
Hau Van Phan
Examiner (ID: 8779, Phone: (571)272-6696 , Office: P/3618 )
| Most Active Art Unit | 3618 |
| Art Unit(s) | 3618, 3613, 3615, 3619, 3611 |
| Total Applications | 2398 |
| Issued Applications | 1830 |
| Pending Applications | 100 |
| Abandoned Applications | 497 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18581507
[patent_doc_number] => 20230263759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => PARENTERAL NUTRITION FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/139195
[patent_app_country] => US
[patent_app_date] => 2023-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18139195
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/139195 | PARENTERAL NUTRITION FORMULATION | Apr 24, 2023 | Pending |
Array
(
[id] => 20218475
[patent_doc_number] => 20250281406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/858619
[patent_app_country] => US
[patent_app_date] => 2023-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18858619
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/858619 | COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | Apr 20, 2023 | Pending |
Array
(
[id] => 18752308
[patent_doc_number] => 20230355530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => PARTICLES COMPRISING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/136012
[patent_app_country] => US
[patent_app_date] => 2023-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18136012
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/136012 | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof | Apr 17, 2023 | Issued |
Array
(
[id] => 20742976
[patent_doc_number] => 12642858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-02
[patent_title] => Long-lasting hydrogel for use against drug-resistant bacteria and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/132978
[patent_app_country] => US
[patent_app_date] => 2023-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 0
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18132978
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/132978 | Long-lasting hydrogel for use against drug-resistant bacteria and preparation method and use thereof | Apr 10, 2023 | Issued |
Array
(
[id] => 19496371
[patent_doc_number] => 20240335389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => PLANT-BASED HARD CAPSULE FOR RAPID DISINTEGRATION AND METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/131908
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131908
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131908 | PLANT-BASED HARD CAPSULE FOR RAPID DISINTEGRATION AND METHOD THEREOF | Apr 6, 2023 | Pending |
Array
(
[id] => 18656057
[patent_doc_number] => 20230301923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/131715
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131715
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131715 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Apr 5, 2023 | Issued |
Array
(
[id] => 18909345
[patent_doc_number] => 11872308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Dry powder formulations of epinephrine and associated methods
[patent_app_type] => utility
[patent_app_number] => 18/128705
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 132
[patent_no_of_words] => 46535
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128705
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128705 | Dry powder formulations of epinephrine and associated methods | Mar 29, 2023 | Issued |
Array
(
[id] => 18737850
[patent_doc_number] => 20230346750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => 5HT AGONISTS FOR TREATING DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/192955
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192955
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/192955 | 5HT agonists for treating disorders | Mar 29, 2023 | Issued |
Array
(
[id] => 18535897
[patent_doc_number] => 20230240983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/192404
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/192404 | Dry powder formulations of epinephrine and associated methods | Mar 28, 2023 | Issued |
Array
(
[id] => 18747087
[patent_doc_number] => 11806378
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-07
[patent_title] => Therapeutic composition including phenolic compounds derived from Opuntia littoralis
[patent_app_type] => utility
[patent_app_number] => 18/125106
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 3315
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18125106
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/125106 | Therapeutic composition including phenolic compounds derived from Opuntia littoralis | Mar 21, 2023 | Issued |
Array
(
[id] => 18496104
[patent_doc_number] => 20230218647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => BORTEZOMIB COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/188384
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188384
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188384 | Bortezomib compositions | Mar 21, 2023 | Issued |
Array
(
[id] => 20144001
[patent_doc_number] => 12378329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Zwitterionically modified polymers and hydrogels
[patent_app_type] => utility
[patent_app_number] => 18/122416
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 32
[patent_no_of_words] => 16401
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122416 | Zwitterionically modified polymers and hydrogels | Mar 15, 2023 | Issued |
Array
(
[id] => 20385383
[patent_doc_number] => 12485092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Composition for promoting drug release of drug-delivery liposomes
[patent_app_type] => utility
[patent_app_number] => 18/122284
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 6962
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122284
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122284 | Composition for promoting drug release of drug-delivery liposomes | Mar 15, 2023 | Issued |
Array
(
[id] => 20039093
[patent_doc_number] => 20250177315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => PRE-FUNCTIONALIZED HARD SHELL CAPSULE WITH ACCELERATED DRUG RELEASE AT PH VALUE 5 TO 5.5
[patent_app_type] => utility
[patent_app_number] => 18/846094
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18846094
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/846094 | PRE-FUNCTIONALIZED HARD SHELL CAPSULE WITH ACCELERATED DRUG RELEASE AT PH VALUE 5 TO 5.5 | Mar 5, 2023 | Pending |
Array
(
[id] => 18672868
[patent_doc_number] => 20230310314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/175442
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175442
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175442 | MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS | Feb 26, 2023 | Abandoned |
Array
(
[id] => 19700103
[patent_doc_number] => 12194102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances
[patent_app_type] => utility
[patent_app_number] => 18/175020
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7333
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175020
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175020 | Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances | Feb 26, 2023 | Issued |
Array
(
[id] => 19310397
[patent_doc_number] => 12036191
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-07-16
[patent_title] => Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
[patent_app_type] => utility
[patent_app_number] => 18/169571
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7711
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169571
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169571 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan | Feb 14, 2023 | Issued |
Array
(
[id] => 19674589
[patent_doc_number] => 12186427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Fulvestrant formulations and methods of their use
[patent_app_type] => utility
[patent_app_number] => 18/109421
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 35526
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/109421 | Fulvestrant formulations and methods of their use | Feb 13, 2023 | Issued |
Array
(
[id] => 18800078
[patent_doc_number] => 11833224
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-05
[patent_title] => Lyoprotectant compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/166416
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 8286
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166416 | Lyoprotectant compositions and uses thereof | Feb 7, 2023 | Issued |
Array
(
[id] => 20005807
[patent_doc_number] => 20250144029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => NOVEL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/832674
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18832674
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/832674 | NOVEL COMPOSITIONS | Jan 26, 2023 | Pending |